{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3696, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "Includes both a longitudinal line chart of IRAK4 reduction and a grouped bar chart with a summary table for cytokine inhibition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/11", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-11", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Includes PK/PD correlation, IRAK4 levels in PBMC, and skin lesion reduction data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/12", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-12", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide displays 12 bar charts representing log2(fold change) for specific genes across individual patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/13", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-13", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "analyze_data", "notes": "Includes error bars representing standard error of the mean; data points are plotted over 42 days.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/14", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-14", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/15", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-15", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "Data includes error bars representing standard error of the mean (S.E. of Mean) or 80% confidence intervals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/16", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-16", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/17", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-17", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide highlights a favorable safety profile with no serious adverse events (SAEs) or drug-related infections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/18", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-18", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "Focuses on partnership dynamics and clinical progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/19", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-19", "loopMatches": [ { "to": 19, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "481e5a5e-15c9-4f41-910c-aaa935cd7dad", "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 1, "objective": "What are the potential benefits of Kymera's platform?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 19, "from": 10, "beatId": "76c0c72b-c82b-4ac5-891b-8e3593c8cc1e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The deck showcases encouraging clinical data for lead programs.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "Includes clinical trial identifiers and definitions of acronyms in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/20", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "section_divider", "function": "transition", "notes": "The slide uses an abstract, scientific-looking background, likely representing molecular or biological structures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/21", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "solution", "function": "present_solution", "notes": "Includes a table of prevalence/incidence for various indications and a diagram of the JAK-STAT signaling pathway.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/22", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a dual-chart layout to correlate tumor volume reduction with PK/PD profiles.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/23", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a process flow diagram to illustrate the dose escalation (0.05 to 0.40 mg/kg) leading to MTD/RP2D expansion into four specific patient cohorts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/24", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays adverse events occurring in 2 or more patients. Data includes patient counts and percentages for both 'All' and 'Related' adverse events.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/25", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a line chart showing plasma concentration over time and a table summarizing PK parameters (Cmax, AUClast, Vd, CL, t1/2).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/26", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "traction", "function": "show_traction", "notes": "Data presented as % change from C1D1 Predose. Includes time course line chart and dot plot for maximum degradation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/27", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "traction", "function": "show_traction", "notes": "Data from a clinical study of KT-333, showing biomarker response across different dose levels (DL1, DL2, DL3).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/28", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "traction", "function": "show_traction", "notes": "Includes ASH logo and specific clinical trial metrics (DL levels, AE types).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/29", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a split-layout: left side for clinical data results, right side for strategic positioning.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/30", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/31", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "solution", "function": "present_solution", "notes": "Includes a waterfall plot of cell line dependency and a biological process diagram showing the MDM2-p53 feedback loop.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/32", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Includes three dose-response curves and a comparative table of clinical stage and potency metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/33", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "solution", "function": "present_solution", "notes": "Comparison of KT-253 vs DS-3032 (SMI) across protein levels and tumor volume over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/34", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a visual representation of the dose escalation study design and a detailed table of patient baseline characteristics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/35", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "traction", "function": "show_traction", "notes": "The slide combines a biological mechanism diagram with clinical trial data (table and line chart) to validate the drug's mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/36", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "traction", "function": "show_traction", "notes": "Swimmer plot showing days on study for three patients, with corresponding CT scan imagery for one patient.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/37", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_data", "function": "analyze_data", "notes": "Clinical trial safety reporting slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/38", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a split-layout to contrast technical mechanism/data (left) with strategic market opportunity (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/39", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/40", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 40, "beatId": "e40b2b30-8873-47b3-a300-33722ca94191", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "The deck outlines upcoming milestones and events.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4eee-72eb-9f75-bef42550a1c1", "docSlug": "3c2d586ebe2940705b3e5004470d76e3", "documentTitle": "Kymera | Investor Presentation Deck | 41 slides", "authorId": "kymera", "authorName": "Kymera", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "appendix", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4eee-72eb-9f75-bef42550a1c1/41", "deckHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1", "deckAnchorHref": "/decks/019de076-4eee-72eb-9f75-bef42550a1c1#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 40, "beatId": "e40b2b30-8873-47b3-a300-33722ca94191", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "The deck outlines upcoming milestones and events.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/0wS852DLBBIg4AQjrQCeUxE8_K4ASF9Mm_hFn3opVvQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xYWYyZDQxNTZiZjI0OTBiM2FjMjgwMWI1NDg3YWJkZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/1", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/PUkcyKImM3nLNqXIyLFxWQ3bo1bhqa7UAItMlfws2hA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xYWYyZDQxNTZiZjI0OTBiM2FjMjgwMWI1NDg3YWJkZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/kKVbuBZ3EYX61k6ndDzCoLvuI82q-eVuOrEaUyL7nlU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xYWYyZDQxNTZiZjI0OTBiM2FjMjgwMWI1NDg3YWJkZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/QaZkO-RIenmBPOtlaLaawxF58Q1gwP5LnuBu7zKXVnw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xYWYyZDQxNTZiZjI0OTBiM2FjMjgwMWI1NDg3YWJkZi9wMDAxLnBuZw" }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/2", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a list-based layout to present key company milestones and financial health.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/3", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 3, "beatId": "eecc221a-f59e-4dc4-9762-a4322f3ac6c2", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Executive Summary", "beatSlug": null, "evidence": "A brief summary of investment highlights is provided on page 3", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a two-column layout to contrast the current Phase 2 trial status with the upcoming OLE trial status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/4", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "unfair_advantage", "function": "cite_precedent", "notes": "The slide uses a timeline framework to demonstrate long-term IP protection.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/5", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a medical context to establish the severity of the condition and the unmet medical need.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/6", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-6", "loopMatches": [ { "to": 7, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "59b04e7b-c635-4d71-b3eb-06c09a7648ae", "evidence": "Pages 6-7 discuss the disease progression and impact", "position": 0, "objective": "What is the cost of not treating FA?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "18a5218e-e93d-4d5a-9052-a99e8d363f59", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The problem is clearly stated on page 6: Friedreich's Ataxia (FA)", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "context", "function": "establish_context", "notes": "The slide uses clinical data to establish the biological rationale for the therapeutic approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/7", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-7", "loopMatches": [ { "to": 7, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "59b04e7b-c635-4d71-b3eb-06c09a7648ae", "evidence": "Pages 6-7 discuss the disease progression and impact", "position": 0, "objective": "What is the cost of not treating FA?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a visual comparison of protein structures to explain the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/8", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-8", "loopMatches": [ { "to": 9, "from": 8, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "9497e3e4-af2a-4d0d-9695-145c2500b688", "evidence": "Pages 8-9 explain the mechanism of action", "position": 1, "objective": "How does Nomlabofusp work?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 8, "from": 8, "beatId": "18364914-9b49-4201-98dc-45a406e457f0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented on page 8: Nomlabofusp is designed to deliver additional frataxin", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "appendix_data", "function": "analyze_data", "notes": "Details the dosing schedule (13 days) and specific sampling days for buccal cells, skin, and platelets across three dose levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/9", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-9", "loopMatches": [ { "to": 9, "from": 8, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "9497e3e4-af2a-4d0d-9695-145c2500b688", "evidence": "Pages 8-9 explain the mechanism of action", "position": 1, "objective": "How does Nomlabofusp work?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "analyze_data", "notes": "The slide displays two dot plots with error bars representing median and 25th/75th percentiles for FXN concentration changes from baseline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/10", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines the methodology for a clinical trial, specifically focusing on the 28-day treatment schedule and cohort details.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/11", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Data represents median and 25th/75th percentiles. Baseline values provided in footnotes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/12", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide establishes a baseline for FXN levels in healthy individuals to contextualize the deficiency seen in Friedreich's Ataxia (FA) patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/13", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide highlights high completion rates and manageable adverse events, specifically noting injection site reactions (ISRs) as the most common side effect.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/14", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "roadmap", "function": "plan_implementation", "notes": "FACOMS: Friedreich's Ataxia Clinical Outcome Measures Study", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/15", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-15", "loopMatches": [ { "to": 18, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "b4351c10-987b-4a01-94eb-9553dbddf999", "evidence": "Pages 15-18 discuss the clinical development plan and upcoming milestones", "position": 2, "objective": "What are the near-term milestones?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a clinical development roadmap with specific trial types and status updates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/16", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-16", "loopMatches": [ { "to": 18, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "b4351c10-987b-4a01-94eb-9553dbddf999", "evidence": "Pages 15-18 discuss the clinical development plan and upcoming milestones", "position": 2, "objective": "What are the near-term milestones?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide highlights the unique 'Protein replacement' approach of Nomlabofusp compared to other modalities like Mitochondrial Oxidative Stress Modifiers, Gene Expression Regulators, Pathway Modifiers, and Gene Therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/17", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-17", "loopMatches": [ { "to": 18, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "b4351c10-987b-4a01-94eb-9553dbddf999", "evidence": "Pages 15-18 discuss the clinical development plan and upcoming milestones", "position": 2, "objective": "What are the near-term milestones?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/18", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-18", "loopMatches": [ { "to": 18, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "b4351c10-987b-4a01-94eb-9553dbddf999", "evidence": "Pages 15-18 discuss the clinical development plan and upcoming milestones", "position": 2, "objective": "What are the near-term milestones?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a list-based layout to present key company milestones and status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/19", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/20", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/21", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/22", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "other", "function": "establish_context", "notes": "The slide serves as a credibility-building asset by showcasing a partnership with a key non-profit organization in the rare disease space.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/23", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/24", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "The slide outlines the clinical trial methodology for a drug candidate in Friedreich's Ataxia (FA) patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/25", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide details the dosing schedule (13 days) and specific sampling days for buccal cells, skin, and platelets across three dose cohorts (25mg, 50mg, 100mg).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/26", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "traction", "function": "show_traction", "notes": "The charts display median values with 25th and 75th percentile error bars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/27", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays n (%) for categorical variables and descriptive statistics (mean, SD, median, range) for age.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/28", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303", "docSlug": "1af2d4156bf2490b3ac2801b5487abdf", "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides", "authorId": "larimar-therapeutics", "authorName": "Larimar Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": "MAD likely stands for Multiple Ascending Dose.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/29", "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303", "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 4, "beatId": "800ed350-717e-4cf5-a054-3d6626879633", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Multiple pages showcase clinical trial progress and data", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }